EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients

Lui Ng iD, Ryan Wai-Yan Sin, David Him Cheung, Wai-Keung Leung iD, Abraham Tak-Ka Man, Oswens Siu-Hung Lo iD, Wai-Lun Law, Dominic Chi-Chung Foo

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24109084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Lui Ng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: MicroRNAs, Non-alcoholic Fatty Liver Disease, Colonic Polyps, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Medical Research Fund of the Research Fund Secretariat, Food and Health Bureau, HKSAR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases and its prevalence is increasing worldwide. It is reported that NAFLD is associated with colorectal polyps. Since identifying NAFLD in its early stages could prevent possible disease progression to cirrhosis and decrease the risk of HCC by early intervention, patients with colorectal polyp may thus be considered a target group for screening NAFLD. This study aimed to investigate the potential of serum microRNAs (miRNAs) in identifying NAFLD for colorectal polyp patients. Serum samples were collected from 141 colorectal polyp patients, of which 38 had NAFLD. The serum level of eight miRNAs was determined by quantitative PCR and delta Ct values of different miRNA pairs which were compared between NAFLD and control groups. A miRNA panel was formulated from candidate miRNA pairs by multiple linear regression model and ROC analysis was performed to evaluate its diagnostic potential for NAFLD. Compared to the control group, the NAFLD group showed significantly lower delta Ct values of miR-18a/miR-16 (6.141 vs. 7.374, p = 0.009), miR-25-3p/miR-16 (2.311 vs. 2.978, p = 0.003), miR-18a/miR-21-5p (4.367 vs. 5.081, p = 0.021) and miR-18a/miR-92a-3p (8.807 vs. 9.582, p = 0.020). A serum miRNA panel composed of these four miRNA pairs significantly identified NAFLD in colorectal polyp patients with an AUC value of 0.6584 (p = 0.004). The performance of the miRNA panel was further improved to an AUC value of 0.8337 (p < 0.0001) when polyp patients with other concurrent metabolic disorders were removed from the analysis. The serum miRNA panel is a potential diagnostic biomarker for screening NAFLD in colorectal polyp patients. This serum miRNA test could be performed for colorectal polyp patients for early diagnosis and for prevention of the disease from progressing into more advanced stages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNon-alcoholic Fatty Liver DiseaseColonic PolypsCarcinoma, HepatocellularLiver NeoplasmsHumansEast Asian PeopleBiomarkers, TumorGene Expression ProfilingCase-Control Studies

Stichwörter der Autor:innen

NAFLDcolorectal polypdiagnostic biomarkerserum microRNA (miRNA)

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

ORCID-Profile: Lui Ng, Wai-Keung Leung, Oswens Siu-Hung Lo

Förderung

  • Health and Medical Research Fund of the Research Fund Secretariat, Food and Health Bureau, HKSAR

Zitieren

APA

Ng, L., Sin, R. W., Cheung, D. H., Leung, W. K., Man, A. T., Lo, O. S., Law, W. L., & Foo, D. C. (2023). Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24109084

Vancouver

Ng L, Sin RW, Cheung DH, Leung WK, Man AT, Lo OS, et al. Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24109084

BibTeX
@article{Ng2023,
  author = {Ng, Lui and Sin, Ryan Wai-Yan and Cheung, David Him and Leung, Wai-Keung and Man, Abraham Tak-Ka and Lo, Oswens Siu-Hung and Law, Wai-Lun and Foo, Dominic Chi-Chung},
  title = {Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24109084}
}
Kostenlos starten →